Novavax announced that its coronavirus vaccine was found to be 90% effective overall and 100% effective against moderate and severe cases. The company plans to file for regulatory approval in Q3.
The New Paper
This story is from the June 14, 2021 edition of The New Paper. To receive TNP daily subscribe below.
By subscribing, you agree to our Terms of Service & Privacy Policy.
